Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. Cummings SR, et al. Among authors: nickelsen t. JAMA. 1999 Jun 16;281(23):2189-97. doi: 10.1001/jama.281.23.2189. JAMA. 1999. PMID: 10376571 Clinical Trial.
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Ettinger B, et al. Among authors: nickelsen t. JAMA. 1999 Aug 18;282(7):637-45. doi: 10.1001/jama.282.7.637. JAMA. 1999. PMID: 10517716 Clinical Trial.
Cognitive function in postmenopausal women treated with raloxifene.
Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, Nickelsen T; Multiple Outcomes of Raloxifene Evaluation Investigators. Yaffe K, et al. Among authors: nickelsen t. N Engl J Med. 2001 Apr 19;344(16):1207-13. doi: 10.1056/NEJM200104193441604. N Engl J Med. 2001. PMID: 11309635 Free article. Clinical Trial.
Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
Reginster JY, Felsenberg D, Pavo I, Stepan J, Payer J, Resch H, Glüer CC, Mühlenbacher D, Quail D, Schmitt H, Nickelsen T. Reginster JY, et al. Among authors: nickelsen t. Osteoporos Int. 2003 Sep;14(9):741-9. doi: 10.1007/s00198-003-1432-1. Epub 2003 Jun 19. Osteoporos Int. 2003. PMID: 12827224 Clinical Trial.
A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life.
Voss S, Quail D, Dawson A, Bäckström T, Aguas F, Erenus M, The HS, Bonnar J, De Geyter C, Hunter M, Nickelsen T; Euralox Investigators Group. Voss S, et al. Among authors: nickelsen t. BJOG. 2002 Aug;109(8):874-85. doi: 10.1111/j.1471-0528.2002.01510.x. BJOG. 2002. PMID: 12197366 Clinical Trial.
Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T. Aldrighi JM, et al. Among authors: nickelsen t. Am J Obstet Gynecol. 2004 Dec;191(6):1979-88. doi: 10.1016/j.ajog.2004.04.042. Am J Obstet Gynecol. 2004. PMID: 15592280 Clinical Trial.
60 results